Differences in Tfh Cell Response Between the Graft and Spleen With Chronic Allograft Nephropathy

被引：4
|
作者：
Shi, Jian [1 ]
Xu, Xianlin [1 ]
Luo, Fengbao [1 ]
Shi, Qianqian [1 ]
He, Xiaozhou [1 ]
Xia, Ying [2 ]
机构：
[1] Soochow Univ, Affiliated Hosp 3, Changzhou, Jiangsu, Peoples R China
[2] Univ Texas McGovern Med Sch, Houston, TX USA
来源：
CELL TRANSPLANTATION | 2017年 / 26卷 / 01期
基金：
中国国家自然科学基金;
关键词：
Tfh cell response; Chronic allograft nephropathy (CAN); Renal graft; Spleen; HELPER T-CELLS; ANTIBODY-MEDIATED REJECTION; TRISTETRAPROLIN; DIFFERENTIATION; BAFF; TH17; TRANSPLANTATION; AUTOIMMUNITY; MACROPHAGES; DEFICIENCY;
D O I：
10.3727/096368916X692816
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
The aim of this study was to investigate follicular helper T (Tfh) cell response and its difference between renal graft and spleen in a rat renal transplantation model undergoing chronic allograft nephropathy (CAN). Orthotopical kidney transplantations were performed on Fischer (F344) rats and transplanted to Lewis rats, using syngeneic Lewis Lewis grafts as controls. Tissue samples were collected at 8 weeks posttransplantation. The status of Tfh cell response was assessed by measuring the levels of transcription factor B-cell lymphoma 6 (Bc1-6), interleukin-21 (IL-21), chemoldne receptor type 5 (CXCR5), and B-cell-activating factor belonging to the TNF family (BAFF). Tfh cell response was upregulated in both renal graft and spleen of the CAN group compared to the control group. However, Tfh cell response of the spleen was weaker than that of the graft, which was possibly related to the upregulation of splenic Treg activation. Also, the difference between two tissues was partially associated with the different expressions of tristetraprolin (TTP)/IL-10. Our data help improve our understanding of the role of Tfh cell response in the body with CAN and may provide a valuable clue for better treatment of CAN.
引用
收藏
页码：95 / 102
页数：8
相关论文
共 50 条
  • [21] The association between hyperuricemia at six months after kidney transplantation and the development of new cardiovascular disease, chronic allograft nephropathy, and graft loss
    Akalin, Euver
    Ganeshan, Sri V.
    Winston, Jonathan A.
    Munther, Paul
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 325 - 325
  • [22] Improved long-term graft function in pediatric transplant renal recipients with chronic allograft nephropathy
    Kerecuk, Larissa
    Horsfield, Catherine
    Taylor, Judy
    PEDIATRIC TRANSPLANTATION, 2009, 13 (03) : 324 - 331
  • [23] Impact of chronic allograft nephropathy and subsequent modifications of immunosuppressive therapy on late graft outcomes in renal transplantation
    Montagnino, G
    Banfi, G
    Campise, MR
    Passerini, P
    Aroldi, A
    Cesana, BM
    Ponticelli, C
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (10) : 2622 - 2629
  • [24] Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss
    Moreso, F
    Ibernon, M
    Goma-i-Freixanet, M
    Carrera, M
    Fulladosa, X
    Hueso, M
    Gil-Vernet, S
    Cruzado, JM
    Torras, J
    Grinyó, JM
    Serón, D
    AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (04) : 747 - 752
  • [25] Donor genomics influence graft events: The effect of donor polymorphisms on acute rejection and chronic allograft nephropathy
    Hoffmann, S
    Park, J
    Jacobson, LM
    Muehrer, RJ
    Lorentzen, D
    Kleiner, D
    Becker, YT
    Hullett, DA
    Mannon, R
    Kirk, AD
    Becker, BN
    KIDNEY INTERNATIONAL, 2004, 66 (04) : 1686 - 1693
  • [26] EXPONENTIAL RELATIONSHIP BETWEEN SPLEEN-CELL CONCENTRATION AND FATAL GRAFT VERSUS HOST RESPONSE AFTER TRANSPLANTATION OF ALLOGENEIC SPLEEN-MARROW CELL MIXTURES
    OKUNEWICK, JP
    MEREDITH, RF
    BROZOVICH, BJ
    SEEMAN, PR
    MAGLIERE, K
    TRANSPLANTATION, 1980, 29 (06) : 507 - 510
  • [27] Reduction of postischemic immune inflammatory response:: An effective strategy for attenuating chronic allograft nephropathy
    Herrero-Fresneda, I
    Torras, J
    Vidal, A
    Lloberas, N
    Cruzado, JM
    Grinyó, JM
    TRANSPLANTATION, 2005, 79 (02) : 165 - 173
  • [28] Immunological link between primary graft dysfunction and chronic lung allograft rejection
    Bharat, Ankit
    Kuo, Elbert
    Steward, Nancy
    Aloush, Aviva
    Hachem, Ramsey
    Trulock, Elbert P.
    Patterson, G. Alexander
    Meyers, Bryan F.
    Mohanakumar, T.
    ANNALS OF THORACIC SURGERY, 2008, 86 (01): : 189 - 197
  • [29] The relation between hystopathological findings and survival in renal transplant recipients with chronic allograft nephropathy
    Ozdemir, Abbas
    Apaydin, Suheyla
    Kilicaslan, Isin
    Erek, Ekrem
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 273 - 273
  • [30] Can we improve the outcome of allograft survival in patients with progressive graft dysfunction due to chronic allograft nephropathy (CAN)? A preliminary report.
    Wali, R. K.
    Blahut, S.
    Mohanlal, V.
    Drachenberg, C.
    Philosophe, B.
    Cooper, M.
    Ramos, E.
    Joshi, A.
    Bartlett, S.
    Weir, M. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 525 - 525
12345